Local Immunity in Hematological Patients with Oropharyngeal Candidiasis

E.Yu. Danilovа, N.V. Shabashova, E.V. Frolova, A.E. Uchevatkina, L.V. Filippova

I.I. Mechnikov North-West State Medical University under the Ministry of Health of Russia, 41 Kirochnaya str., Saint Petersburg, Russian Federation, 191015

For correspondence: Evgeniya Yur’evna Danilova, graduate student in the Department of Clinical Mycology, 41 Kirochnaya str., Saint Petersburg, Russian Federation, 191015; Tel.: +7(812)303-51-41; e-mail: danilovaimmuno@yandex.ru

For citation: Danilova EYu, Shabashova NV, Frolova EV, et al. Local Immunity in Hematological Patients with Oropharyngeal Candidiasis. Clinical oncohematology. 2015;8(4):436–441 (In Russ).

DOI: 10.21320/2500-2139-2015-8-4-436-441


Aim. To evaluate the incidence of oropharyngeal candidiasis (OFC) among oncohematological patients depending on the type of the malignancy and anti-tumor treatment, as well as to assess key cytokine levels in saliva samples.

Methods. 430 patients were enrolled in the study, and 85 samples of saliva were collected from patients with OFC (n = 38) and without it. The control group consisted of 19 healthy volunteers.

Results. The OFC incidence was 9 % and it did not depend on the immunomorphological type of the malignancy and the type of chemotherapy. Before the anti-tumor treatment, TNF-a, IL-17 and G-CSF levels in saliva samples were elevated in all patients. The TNF-a (< 0.05) synthesis was decreased after the anti-tumor treatment. Besides, a tendency to reduced G-CSF and IL-17 production was found. In patients with OFC, MCP-1, IL-17, IFN-g levels were decreased.

Conclusion. In OFC patients with hematopoietic and lymphoid tissue malignancies, impairment of basic types of local antifungal protection was found.

Keywords: oropharyngeal candidiasis, hematopoietic and lymphoid tissue malignancies, local immunity, Candida spp.

Received: July 1, 2015

Accepted: November 9, 2015

Read in PDF (RUS)pdficon


  1. Новик А.А., Иванов Р.А. Клеточная терапия. М.: МИА, 2008. 240 с.
    [Novik AA, Ivanov RA. Kletochnaya terapiya. (Cytotherapy.) Moscow: MIA Publ.; 2008. 240 p. (In Russ)]
  2. Шабашова Н.В. Грибы и иммунитет: Учебное пособие. СПб.: СПбМАПО, 2008. 82 с.
    [Shabashova NV. Griby i immunitet: Uchebnoe posobie. (Fungi and immunity: Textbook.) Saint Petersburg: SPbMAPO Publ.; 2008. 82 p. (In Russ)]
  3. Шабашова Н.В. Особенности локального иммунного ответа и его дефекты при орофарингеальном кандидозе (обзор). Проблемы медицинской микологии. 2010;12(4):3–9.
    [Shabashova NV. Characteristics of local immune response and its defects in oropharyngeal candidiasis (review). Problemy meditsinskoi mikologii. 2010;12(4):3–9. (In Russ)]
  4. Leigh JE, Shetty K, Fidel PL. Oral opportunistic infections in HIV-Positive individuals: review and role of mucosal immunity. AIDS Patient Care STDs. 2004;18(8):443–56. doi: 10.1089/1087291041703665.
  5. Данилова Е.Ю., Шабашова Н.В. Частота орофарингеального кандидоза у онкогематологических больных. Вестник гематологии. 2012;18(1):90.
    [Danilova EYu, Shabashova NV. Incidence of oropharyngeal candidiasis in oncohematological patients. Vestnik gematologii. 2012;18(1):90. (In Russ)]
  6. Данилова Е.Ю., Шабашова Н.В., Фролова Е.В. и др. Некоторые особенности локального иммунитета у онкогематологических больных с орофарингеальным кандидозом (тезисы). Цитокины и воспаление. 2014;13(1):92.
    [Danilova EYu, Shabashova NV, Frolova EV, et al. Some feature of local immunity in oncohematological patients with oropharyngeal candidais (abstract). Tsitokiny i vospalenie. 2014;13(1):92. (In Russ)]
  7. Данилова Е.Ю., Шабашова Н.В., Фролова Е.В. и др. Candida spp. в микробиоцинозе полости рта у онкогематологических больных (тезисы). Проблемы медицинской микологии. 2014;16(2):60.
    [Danilova EYu, Shabashova NV, Frolova EV, et al. Candida spp. in microbiocenosis of the oral cavity in oncohematological patients (abstract). Problemy meditsinskoi mikologii. 2014;16(2):60. (In Russ)]
  8. Климко Н.Н., Козлова Я.И., Хостелиди С.Н. Распространенность тяжелых и хронических микотических заболеваний в Российской Федерации по модели Life Program. Проблемы медицинской микологии. 2014;16(1):5.
    [Klimko NN, Kozlova Ya.I, Khostelidi SN. Prevalence of severe and chronic mycotic diseases in the Russian Federation in accordance with the Life Program model. Problemy meditsinskoi mikologii. 2014;16(1):5. (In Russ)]
  9. Conti HR, Baker О, Freeman AF. New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome. Mucos Immunol. 2011;4(4):448–55. doi: 10.1038/mi.2011.5.
  10. Villar CC, Dongari-Bagtzoglou A. Immune defense mechanisms and immunoenhancement strategies in oropharyngeal candidiasis. Exp Rev Mol Med. 2008;10:29. doi: 10.1017/s1462399408000835.
  11. Conti HR, Shen F, Nayyar N, et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exper Med. 2009;206(2):299–311. doi: 10.1084/jem.20081463.
  12. Данилова Е.Ю., Шабашова Н.В., Фролова Е.В. и др. Локальный синтез цитокинов и микробная нагрузка при орофарингеальном кандидозе у больных гемобластозами. Проблемы медицинской микологии. 2015;17(1):8–13.
    [Danilova EYu, Shabashova NV, Frolova EV, et al. Local synthesis of cytokines and microbial load in oropharyngeal candidiasis in patients with hemoblastoses. Problemy meditsinskoi mikologii. 2015;17(1):8–13. (In Russ)]
  13. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest. 1989;84(4):1045–9. doi: 10.1172/jci114265.
  14. Dongari-Bagtzoglou A, Villar CC, Kashleva H. Candida albicans-infected oral epithelial cells augment the anti-fungal activity of human neutrophils in vitro. Med Mycol. 2005;43:545–9. doi: 10.1080/13693780500064557.
  15. Chattopadhyay A. Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons. Infect Immun. 2004;72(4):956–63. doi: 10.1128/iai.72.4.1956-1963.2004.
  16. Edgerton ML, Koshlukova SE, Araujo MW. Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. Antimicrob Agents Chemother. 2000;44(12):3310–6. doi: 10.1128/aac.44.12.3310-3316.2000.